Bayhill Therapeutics

Bayhill Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for.

Launch date

2000

Employees

Market cap

Enterprise valuation

Portola Valley California (HQ)

Date	Investors	Amount	Round
Jan 2004	U.S. Venture Partners Latterell Venture Partners The Vertical Group Morgenthaler Ventures CMEA Ventures	N/A	Series A
May 2005	U.S. Venture Partners Latterell Venture Partners DeNovo Ventures Pappas Capital Montreux Equity Partners Lilly Ventures The Vertical Group Quintiles Morgenthaler Ventures Pac-Link	$35.4m	Series B
Jul 2009	N/A	$10.0m	Early VC
Total Funding		AUD70.2m

Recent News about Bayhill Therapeutics